Irinotecan Hydrochloride Injection, USP, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial, Rx Only, Manufactured for: Ingenius Pharmaceuticals, LLC, Orlando, FL 32839-6408; Manufactured by: Ingenius Pharmaceuticals, GmbH Ticino 6917, Switzerland, NDC 50742-402-05.
Published July 11, 2018 · Recall initiated: June 8, 2018
Summary
FDA records drug Class II recall D-0890-2018, published July 11, 2018 and initiated June 8, 2018. Recalling firm: Ingenus Pharmaceuticals Llc; Status: Terminated; Reported quantity: 34964 vials; Lot: Lot #: 17034-1, 17035-1, 17036-1; Exp. 08/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: High out of specification assay value results for potency.
What to do
Voluntary: Firm initiated · Letter
Get an email if IRINOTECAN HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IRINOTECAN HYDROCHLORIDE
- Manufacturer
- Ingenus Pharmaceuticals Llc
- Distributor
- Nationwide in the USA
- UPC
- 0350742402052
- Lot
- Lot #: 17034-1, 17035-1, 17036-1; Exp. 08/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAIrinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH,June 24, 2020
- FDAIrinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH,June 24, 2020
- FDAESTRADIOL 20mg PELLET, 1-count 3ml amber vial. RX only. Compounded by: Qualgen 14844 Bristol Park Blvd, EdmondJuly 11, 2018
- FDAVIDAS FSH, Ref 30407-01, IVD, Rx. The firm name on the label is bioMerieux SA, France. For use on theJuly 4, 2018
- FDAIrinotecan Hydrochloride Injection, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial per carton, Rx only,November 13, 2013
- FDAIrinotecan Hydrochloride Injection, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial per carton, Rx only,November 13, 2013
Questions about this recall
Was Irinotecan Hydrochloride Injection, USP, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial, Rx Only, Manufactured for: Ingenius Pharmaceuticals, LLC, Orlando, FL 32839-6408; Manufactured by: Ingenius Pharmaceuticals, GmbH Ticino 6917, Switzerland, NDC 50742-402-05. recalled?
Yes. FDA published recall D-0890-2018 on July 11, 2018. Reported hazard: Superpotent Drug: High out of specification assay value results for potency.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IRINOTECAN HYDROCHLORIDE. UPC: 0350742402052.